PetIQ, Inc. (PETQ) PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives and much more. Arrowhead Pharmaceuticals, Inc. (ARWR) Arrowhead Pharmaceuticals, Inc. develops medicines for the […]
Read MorePlus, President Biden and congressional Democrats are moving forward with stimulus, Pfizer said it can deliver 200 million doses of its COVID-19 vaccine to the U.S. by May, and Uber is buying Drizly.
Read MorePlus, the U.S. logged a new record for daily coronavirus cases, Walmart launched its new Walmart Pet Care service, and Ford unveiled its new all-electric Transit van.
Read MorePlus, the UN has called for an investigation into whether the Saudi Crown Prince was involved in hacking Amazon’s Bezos’ iPhone, Tesla got another upgrade, and Boeing said it doesn’t expect regulatory approval for its 737 Max until mid-year.
Read MoreThis stock has gained more than 35% since reporting, but is it a buy?
Read MoreAratana Therapeutics, Inc., a pet therapeutics company, focuses on the licensing, development, and commercialization of therapeutics for dogs and cats in the United States and Belgium. Its product portfolio includes multiple therapeutics and therapeutic candidates in development consisting of small molecule pharmaceuticals and biologics. The company markets ENTYCE for appetite stimulation in dogs; GALLIPRANT for […]
Read More